— Know what they know.
Not Investment Advice

KRMD NASDAQ

KORU Medical Systems, Inc.
1W: -1.9% 1M: -4.2% 3M: -21.0% YTD: -43.7% 1Y: -21.8% 3Y: +25.4% 5Y: -2.8%
$3.16
+0.01 (+0.32%)
 
Weekly Expected Move ±2.8%
$3 $3 $3 $3 $3
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 37 · $145.1M mcap · 43M float · 0.412% daily turnover · Short 52% of daily vol
Smart Money Score
Moderate 50
Insider+$0.2M
Congress
ETF Holdings
Key Statistics
Market Cap$145.1M
52W Range3.115-6.608
Volume129,454
Avg Volume176,685
Beta0.42
Dividend
Analyst Ratings
4 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOAdam Kalbermatten
Employees73
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date1994-04-05
100 Corporate Drive
Mahwah, NY 07430
US
845 469 2042
About KORU Medical Systems, Inc.

KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.

Recent Insider Trades

NameTypeSharesPriceDate
KALBERMATTEN ADAM R P-Purchase 32,000 $3.16 2026-09-08
KALBERMATTEN ADAM R M-Exempt 75,000 2026-07-28
KALBERMATTEN ADAM R F-InKind 25,483 $4.26 2026-07-28
KALBERMATTEN ADAM R A-Award 284,091 2026-07-01
KALBERMATTEN ADAM R A-Award 286,697 2026-07-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms